Status:
UNKNOWN
Assessment of Balance in Patients With Pes Planus
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Pes Planus
Fall Risk
Eligibility:
All Genders
50-65 years
Phase:
NA
Brief Summary
Introduction: Pes planus is a foot deformity with increased contact of the foot with the ground as a result of the decrease or disappearance of the medial longitudinal arch of the foot. The arch of th...
Detailed Description
Materials and Methods: 34 cases with pes planus will be included in the study. Medial longitudinal arch height of all cases will be evaluated by physical examination . Affected foot, presence of "too ...
Eligibility Criteria
Inclusion
- Patients aged 50 years and above with pes planus according to Staheli Arch Index and Chippaux- Smirak Index
Exclusion
- Congenital anomalies of the foot
- Prior lower extremity surgery Inflammatory arthritis
- Neuromuscular diseases
- Diseases that interfere with lower extremity circulation
- Presence of orthostatic hypotension
- Untreated visual impairment
- Neurological and vestibular diseases
- Use of drugs that can cause balance disorders (Antipsychotics, Pregabalin, etc.)
Key Trial Info
Start Date :
April 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05320003
Start Date
April 6 2022
End Date
May 15 2022
Last Update
April 11 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.